98%
921
2 minutes
20
Amyloid-based prions have simple structures, a wide phylogenetic distribution, and a plethora of functions in contemporary organisms, suggesting they may be an ancient phenomenon. However, this hypothesis has yet to be addressed with a systematic, computational, and experimental approach. Here we present a framework to help guide future experimental verification of candidate prions with conserved functions to understand their role in the early stages of evolution and potentially in the origins of life. We identified candidate prions in all high-quality proteomes available in UniProt computationally, assessed their phylogenomic distributions, and analyzed candidate-prion functional annotations. Of the 27 980 560 proteins scanned, 228 561 were identified as candidate prions (~0.82%). Among these candidates, there were 84 Gene Ontology (GO) terms conserved across the three domains of life. We found that candidate prions with a possible role in adaptation were particularly well-represented within this group. We discuss unifying features of candidate prions to elucidate the primeval roles of prions and their associated functions. Candidate prions annotated as transcription factors, DNA binding, and kinases are particularly well suited to generating diverse responses to changes in their environment and could allow for adaptation and population expansion into more diverse environments. We hypothesized that a relationship between these functions and candidate prions could be evolutionarily ancient, even if individual prion domains themselves are not evolutionarily conserved. Candidate prions annotated with these universally occurring functions potentially represent the oldest extant prions on Earth and are therefore excellent experimental targets.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/prot.26558 | DOI Listing |
Medicine (Baltimore)
August 2025
Department of Health Medical Big Data Office, Statistical Information Center of the National Health Commission, Beijing, China.
This study developed a prognostic risk prediction model for endometrial carcinoma (EC) by integrating data from The Cancer Genome Atlas and Gene Expression Omnibus for bioinformatics analysis. The relevant data of EC were downloaded from The Cancer Genome Atlas database and the GSE17025 dataset of the Gene Expression Omnibus database. Based on the R language, the differentially expressed genes (DEGs) and weighted gene co-expression network analysis were used to identify the gene modules with the strongest correlation with clinical features, and intersected with the DEGs of GSE17025 dataset.
View Article and Find Full Text PDFAMB Express
August 2025
Department of Neurology, The First Hospital of Jilin University, Changchun, China.
While gut microbiome associations with sporadic Creutzfeldt-Jakob disease (sCJD) are recognized, causal mechanisms and mediation via cerebrospinal fluid (CSF) metabolites remain unestablished. Using bidirectional Mendelian randomization (MR) with mediation analysis and integrating genome-wide association study (GWAS) summary statistics from gut microbiota (composition in the FINRISK 2002 prospective cohort, n = 5,959), CSF metabolites (from the Wisconsin Alzheimer's Disease Research Center Registry and Wisconsin Registry for Alzheimer's Prevention, n = 291), and sCJD case-control data (5,208 cases vs. 511,675 controls), we identified five microbial taxa influencing sCJD risk.
View Article and Find Full Text PDFbioRxiv
June 2025
Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
Tau aggregates propagate through the brain in a prion-like manner in Alzheimer's disease (AD) and other tauopathies, but the molecular identity and functional partners of the seeding-competent Tau species remain poorly defined. Here, we present an unbiased proteomic profiling of a high-molecular-weight (HMW) Tau-seed isolated from AD patient brains. We contrast this interactome with that of a biochemically similar, seeding-incompetent HMW-Tau species from age-matched healthy controls.
View Article and Find Full Text PDFJCI Insight
July 2025
Calgary Prion Research Unit, Faculty of Veterinary Medicine.
Prion diseases are fatal, infectious, and incurable neurodegenerative conditions affecting humans and animals, caused by the misfolding of the cellular prion protein (PrPC) into its pathogenic isoform, PrPSc. In humans, sporadic Creutzfeldt-Jakob disease (sCJD) is the most prevalent prion disease. Recently, we demonstrated that treatment with the FDA-approved anti-HIV drug efavirenz (EFV) significantly reduced PrPSc and extended survival of scrapie prion-infected mice.
View Article and Find Full Text PDFRev Neurosci
June 2025
Department of Biomedical Sciences, Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, 47500, Selangor, Malaysia.
Biomarkers are necessary tools to validate the diagnosis of Alzheimer's and Parkinson's diseases (AD and PD), especially when clinical symptoms are less apparent in the early stages of diseases. Current biomarkers used in clinical practice rely on brain imaging and cerebrospinal fluid (CSF) levels of amyloid-β (Aβ) peptides and α-synuclein (α-syn) for AD and PD, respectively. However, these diagnostic techniques are not only highly invasive and costly, but they also face limitations in diagnostic accuracy, particularly for preclinical or early stages of diseases.
View Article and Find Full Text PDF